FI880941A0 - Förfarande för framställning av terapeutiskt användbara piperazinyl-heterocykliska föreningar - Google Patents
Förfarande för framställning av terapeutiskt användbara piperazinyl-heterocykliska föreningarInfo
- Publication number
- FI880941A0 FI880941A0 FI880941A FI880941A FI880941A0 FI 880941 A0 FI880941 A0 FI 880941A0 FI 880941 A FI880941 A FI 880941A FI 880941 A FI880941 A FI 880941A FI 880941 A0 FI880941 A0 FI 880941A0
- Authority
- FI
- Finland
- Prior art keywords
- preparation
- heterocyclic compounds
- therapeutically useful
- piperazinyl
- piperazinyl heterocyclic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
- C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
- C07D263/58—Benzoxazoles; Hydrogenated benzoxazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/32—Oxygen atoms
- C07D209/34—Oxygen atoms in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/26—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
- C07D277/62—Benzothiazoles
- C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Psychiatry (AREA)
- Anesthesiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
- Indole Compounds (AREA)
- Quinoline Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US8700423 | 1987-03-02 | ||
US8700423 | 1987-03-02 |
Publications (4)
Publication Number | Publication Date |
---|---|
FI880941A0 true FI880941A0 (sv) | 1988-03-01 |
FI880941A FI880941A (sv) | 1988-09-03 |
FI91868B FI91868B (sv) | 1994-05-13 |
FI91868C FI91868C (sv) | 1994-08-25 |
Family
ID=22202301
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI880941A FI91868C (sv) | 1987-03-02 | 1988-03-01 | Förfarande för framställning av terapeutiskt användbara piperazinyl-heterocykliska föreningar |
Country Status (31)
Country | Link |
---|---|
EP (1) | EP0281309B1 (sv) |
JP (1) | JPH0710837B2 (sv) |
KR (1) | KR900003492B1 (sv) |
CN (1) | CN1015057B (sv) |
AR (1) | AR244673A1 (sv) |
AT (1) | ATE70833T1 (sv) |
AU (1) | AU583762B2 (sv) |
BA (1) | BA98296A (sv) |
CA (1) | CA1300139C (sv) |
CZ (1) | CZ281257B6 (sv) |
DD (1) | DD272077A5 (sv) |
DE (3) | DE10299021I1 (sv) |
DK (1) | DK173065B1 (sv) |
EG (1) | EG18398A (sv) |
ES (1) | ES2040838T3 (sv) |
FI (1) | FI91868C (sv) |
GR (1) | GR3003459T3 (sv) |
HU (1) | HU207860B (sv) |
IE (1) | IE60849B1 (sv) |
IL (1) | IL85495A (sv) |
LU (1) | LU90944I2 (sv) |
MX (1) | MX173362B (sv) |
MY (1) | MY103352A (sv) |
NO (2) | NO170977C (sv) |
NZ (1) | NZ223694A (sv) |
PH (1) | PH24119A (sv) |
PL (1) | PL157897B1 (sv) |
PT (1) | PT86866B (sv) |
SU (1) | SU1644716A3 (sv) |
YU (1) | YU46639B (sv) |
ZA (1) | ZA881447B (sv) |
Families Citing this family (65)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS60130573A (ja) * | 1983-12-15 | 1985-07-12 | Otsuka Pharmaceut Co Ltd | ベンゾチアゾ−ル誘導体 |
US4720297A (en) * | 1985-09-27 | 1988-01-19 | Sumitomo Chemical Company, Limited | Benzothiazolones, and their production and use as herbicides |
US4883795A (en) * | 1988-01-22 | 1989-11-28 | Pfizer Inc. | Piperazinyl-heterocyclic compounds |
FR2631625B1 (fr) * | 1988-05-17 | 1992-10-16 | Synthelabo | Derives de phenyl-6 piperazinylalkyl-3 1h,3h-pyrimidinedione-2,4, leur preparation et leur application en therapeutique |
US4957916A (en) * | 1988-08-05 | 1990-09-18 | Janssen Pharmaceutica N.V. | Antipsychotic 3-piperazinylbenzazole derivatives |
US5015740A (en) * | 1988-08-05 | 1991-05-14 | Janssen Pharmaceutica N.V. | Antipsychotic 3-piperazinylbenzazole derivatives |
WO1990006303A1 (en) * | 1988-12-02 | 1990-06-14 | Pfizer Inc. | Arylpiperidine derivatives |
WO1991000863A1 (en) * | 1989-07-07 | 1991-01-24 | Pfizer Inc. | Heteroaryl piperazine antipsychotic agents |
EP0429341A3 (en) * | 1989-11-20 | 1991-11-13 | Rhone-Poulenc Sante | Heterocyclic derivatives, their preparation and pharmaceuticals containing them |
FR2655042B1 (fr) * | 1989-11-29 | 1994-01-21 | Adir Cie | Nouvelles benzothiazolinones substituees, leur procede de preparation et les compositions pharmaceutiques qui les contiennent. |
FR2655988B1 (fr) * | 1989-12-20 | 1994-05-20 | Adir Cie | Nouveaux derives de la napht-1-yl piperazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent. |
US5162324A (en) * | 1989-12-20 | 1992-11-10 | Adir Et Compagnie | Naphyl piperazines useful as 5-HT1A receptor ligands |
US5162321A (en) * | 1989-12-20 | 1992-11-10 | Adir Et Compagnie | 1-naphthyl piperazines useful as 5-HT1A receptor ligands |
US5166157A (en) * | 1989-12-20 | 1992-11-24 | Adir Et Compagnie | Naphthyl piperazines useful as 5-HT1A receptor ligands |
US5166156A (en) * | 1989-12-20 | 1992-11-24 | Adir Et Compagnie | Naphthyl piperazines useful as 5-HT1A receptor ligands |
FR2671350A1 (fr) * | 1991-01-08 | 1992-07-10 | Adir | Nouveaux derives de benzisoxazole et de benzisothiazole, leur procede de preparation, et les compositions pharmaceutiques les renfermant. |
FR2667068B1 (fr) * | 1990-09-26 | 1994-09-09 | Adir | Nouvelles amines alkyl heterocycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent. |
US5268381A (en) * | 1990-09-26 | 1993-12-07 | Adir Et Compagnie | Aminoalkyl-benzothiazolinone and -benzoxazolinone compounds having a high 5-HT1A affinity |
US5147881A (en) * | 1990-11-14 | 1992-09-15 | Pfizer Inc | 4-(1,2-benzisoxazolyl)piperidine antipsychotic agents |
US5643784A (en) * | 1990-12-04 | 1997-07-01 | H, Lundbeck A/S | Indan derivatives |
FR2674524B1 (fr) * | 1991-03-25 | 1993-05-21 | Adir | Nouveaux amides alkyl heterocycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent. |
NZ243065A (en) * | 1991-06-13 | 1995-07-26 | Lundbeck & Co As H | Piperidine derivatives and pharmaceutical compositions |
DK55192D0 (da) * | 1992-04-28 | 1992-04-28 | Lundbeck & Co As H | 1-piperazino-1,2-dihydroindenderivater |
DK78692D0 (da) * | 1992-06-12 | 1992-06-12 | Lundbeck & Co As H | Dimere piperidin- og piperazinderivater |
US5206366A (en) * | 1992-08-26 | 1993-04-27 | Pfizer Inc. | Process for preparing aryl piperazinyl-heterocyclic compounds |
US5312925A (en) * | 1992-09-01 | 1994-05-17 | Pfizer Inc. | Monohydrate of 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)-ethyl)-6-chloro-1,3-dihydro-2H-indol-2-one-hydrochloride |
DK148392D0 (da) * | 1992-12-09 | 1992-12-09 | Lundbeck & Co As H | Heterocykliske forbindelser |
KR0179063B1 (ko) * | 1993-02-04 | 1999-03-20 | 사사이 아키라 | 항정신병 작용을 갖는 화합물 |
FR2702214B1 (fr) * | 1993-03-05 | 1995-04-14 | Adir | Nouveaux composés (aryl(alkyl)carbonyl)-hétérocycliques, leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent. |
GB9305623D0 (en) * | 1993-03-18 | 1993-05-05 | Merck Sharp & Dohme | Therapeutic agents |
ES2083319B1 (es) * | 1993-09-20 | 1997-01-16 | Pfizer | Monohidrato de clorhidrato de 5-(2-(4-(1,2-benzisotiazol-3-il)-1-piperazinil)-etil)-6-cloro-1,3-dihidro-2h-indol-2-ona. |
AU687155B2 (en) * | 1994-03-22 | 1998-02-19 | Les Laboratoires Servier | Novel aminoalkyl benzothiazolinones, process for their preparation and the pharmaceutical compositions which contain them |
FR2717807B1 (fr) * | 1994-03-22 | 1996-04-19 | Adir | Nouvelles 6- [(4-arylalkyl-1-piperazino)alkyl] benzothiazolinones, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent. |
JP3274579B2 (ja) * | 1995-01-12 | 2002-04-15 | 住友製薬株式会社 | 脳血管障害に伴う精神症候治療剤 |
US6187774B1 (en) * | 1996-03-04 | 2001-02-13 | Yoshitomi Pharmaceutical Industries, Ltd. | Fused heterocyclic compounds and pharmaceutical applications thereof |
TW491847B (en) | 1996-05-07 | 2002-06-21 | Pfizer | Mesylate dihydrate salts of 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)-ethyl)-6-chloro-1,3-dihydro-2h-indol-2-one |
UA57734C2 (uk) | 1996-05-07 | 2003-07-15 | Пфайзер Інк. | Комплекси включення арилгетероциклічних солей |
AU730856C (en) * | 1996-05-07 | 2001-11-15 | Pfizer Inc. | Mesylate trihydrate salt of 5-(2-(4-(1,2-benzisothiazol- 3-yl)-1-piperazinyl)ethyl)-6-chloro-1,3-dihydro-2(1H)- indol-2-one(=ziprasidone),it's preparation and it's use as dopamine D2 antagonist |
FR2755690B1 (fr) * | 1996-11-08 | 1998-12-18 | Adir | Nouveaux derives aminomethyl heterocycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
US6150366A (en) * | 1998-06-15 | 2000-11-21 | Pfizer Inc. | Ziprasidone formulations |
AR030357A1 (es) | 2000-08-18 | 2003-08-20 | Lundbeck & Co As H | Derivados 4 -, 5 -, 6 - y 7-indol |
DE60231507D1 (de) | 2001-07-20 | 2010-07-01 | Psychogenics Inc | Behandlung von hyperaktivitätsstörungen und aufmerksamkeitsdefiziten |
US20060089400A1 (en) * | 2002-05-03 | 2006-04-27 | The Vernalis Group Of Companies | Novel spiro ketone and carboxylic acid derivatives as specific inhibitors for (po3h2) ser/(po3h2)thr-pro-specific peptidyl-prolylcis/trans-isomerases |
MXPA05003658A (es) * | 2002-10-28 | 2005-06-08 | Warner Lambert Co | Derivados de piperazina sustituidos con oxindol. |
WO2004100956A1 (en) * | 2003-05-16 | 2004-11-25 | Pfizer Products Inc. | Method for enhancing cognition using ziprasidone |
JP2007502856A (ja) * | 2003-05-16 | 2007-02-15 | ファイザー・プロダクツ・インク | 精神病性障害および抑うつ性障害の治療 |
WO2004100955A1 (en) * | 2003-05-16 | 2004-11-25 | Pfizer Products Inc. | Anxiety treatments with ziprasidone |
HUP0400953A3 (en) * | 2004-05-11 | 2008-02-28 | Egis Gyogyszergyar Nyilvanosan | Piperazine derivatives of alkyl-oxindoles, pharmaceutical compositions containing them, process for producing them and their use |
KR20070011551A (ko) * | 2004-05-11 | 2007-01-24 | 에지스 지오기스제르기아르 엔와이알티. | 알킬 옥스인돌의 피페라진 유도체 |
WO2006011157A2 (en) * | 2004-06-18 | 2006-02-02 | Lupin Limited | Methods for the preparation of aryl piperazinyl-heterocyclic compounds |
ES2250000B1 (es) * | 2004-09-29 | 2007-06-01 | Medichem, S.A. | Procedimiento para la preparacion de ziprasidona. |
JO2769B1 (en) | 2005-10-26 | 2014-03-15 | جانسين فارماسوتيكا ان. في | Rapid decomposition of physiologically antagonistic agents of the 2-dopamine receptor |
HUP0600868A3 (en) * | 2006-11-24 | 2009-03-30 | Richter Gedeon Nyrt | 5-{2-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]ethyl}-6-chloro-1,3-dihydro-2h-indol-2-one hydrogen bromide polimorphs and process for their preparation |
JO2642B1 (en) | 2006-12-08 | 2012-06-17 | جانسين فارماسوتيكا ان. في | Dopamine 2 receptor antagonists are rapidly hydrolyzed |
JO2849B1 (en) * | 2007-02-13 | 2015-03-15 | جانسين فارماسوتيكا ان. في | Dopamine 2 receptor antagonists are rapidly hydrolyzed |
AU2008240729B2 (en) | 2007-04-23 | 2012-08-23 | Janssen Pharmaceutica N.V. | Thia(dia)zoles as fast dissociating dopamine 2 receptor antagonists |
DK2148873T3 (da) | 2007-04-23 | 2012-11-26 | Janssen Pharmaceutica Nv | 4-alkoxypyridazinderivater som hurtigt dissocierende dopamin 2- receptorantagonister |
ES2398625T3 (es) | 2008-07-03 | 2013-03-20 | Janssen Pharmaceutica N.V. | 6-(1-Piperazinil)-piritazinas sustituidas como antagonistas de receptores 5-HT6 |
ES2622161T3 (es) | 2008-07-31 | 2017-07-05 | Janssen Pharmaceutica, N.V. | Piridinas sustituidas con piperazin-1-il-trifluorometilo como antagonistas del receptor de la dopamina 2 de disociación rápida |
PL2445502T5 (pl) * | 2009-06-25 | 2023-03-13 | Alkermes Pharma Ireland Limited | Związki heterocykliczne do leczenia zaburzeń neurologicznych i psychologicznych |
PL391810A1 (pl) | 2010-07-14 | 2012-01-16 | Zakłady Farmaceutyczne POLPHARMA Spółka Akcyjna | Nowe sole ziprasidonu oraz sposoby ich otrzymywania |
SI23610A (sl) | 2011-01-13 | 2012-07-31 | Diagen@d@o@o | Nove adicijske soli ziprasidona postopek za njihovo pripravo in njihova uporaba v terapiji |
WO2014078568A1 (en) | 2012-11-14 | 2014-05-22 | The Johns Hopkins University | Methods and compositions for treating schizophrenia |
MA41169A (fr) * | 2014-12-17 | 2017-10-24 | Acraf | Composés antibactériens à large spectre d'activité |
JP7384812B2 (ja) | 2018-03-05 | 2023-11-21 | アルカームス ファーマ アイルランド リミテッド | アリピプラゾール投与戦略 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4179505A (en) * | 1977-03-30 | 1979-12-18 | Janssen Pharmaceutica N.V. | 5-[4-(Diarylmethyl)-1-piperazinylalkyl]benzimidazole derivatives |
FR2536749A1 (fr) * | 1982-11-25 | 1984-06-01 | Cerm Cent Europ Rech Mauvernay | (amino-2 ethyl)-6 benzoxazolinones substituees, leur preparation et leurs applications en therapeutique |
US4554284A (en) * | 1984-09-12 | 1985-11-19 | Smithkline Beckman Corporation | 7-(2-Aminoethyl)-1,3-benzthia- or oxa-zol-2(3H)-ones |
JPH0625181B2 (ja) * | 1985-03-27 | 1994-04-06 | 住友製薬株式会社 | 新規なイミド誘導体 |
ZA864632B (en) * | 1985-06-22 | 1988-02-24 | Sandoz Ltd | Thiazoles,their production and pharmaceutical compositions containing them |
HUT43600A (en) * | 1985-06-22 | 1987-11-30 | Sandoz Ag | Process for production of new thiazole derivatives and medical compound containing those |
MX174210B (es) * | 1987-02-17 | 1994-04-28 | Pfizer | Procedimiento para la preparacion de compuestos arilpiperazinil-alquilenfenil-p-heterociclicos |
-
1987
- 1987-03-02 MX MX1062188A patent/MX173362B/es unknown
-
1988
- 1988-02-22 IL IL85495A patent/IL85495A/xx not_active IP Right Cessation
- 1988-02-24 DE DE2002199021 patent/DE10299021I1/de active Pending
- 1988-02-24 DE DE8888301561T patent/DE3867089D1/de not_active Expired - Lifetime
- 1988-02-24 DE DE19883867089 patent/DE10299021I2/de active Active
- 1988-02-24 EP EP88301561A patent/EP0281309B1/en not_active Expired - Lifetime
- 1988-02-24 ES ES198888301561T patent/ES2040838T3/es not_active Expired - Lifetime
- 1988-02-24 AT AT88301561T patent/ATE70833T1/de active
- 1988-02-29 PT PT86866A patent/PT86866B/pt active IP Right Grant
- 1988-02-29 CA CA000560086A patent/CA1300139C/en not_active Expired - Lifetime
- 1988-03-01 ZA ZA881447A patent/ZA881447B/xx unknown
- 1988-03-01 MY MYPI88000206A patent/MY103352A/en unknown
- 1988-03-01 SU SU884355508A patent/SU1644716A3/ru active
- 1988-03-01 IE IE57488A patent/IE60849B1/en not_active IP Right Cessation
- 1988-03-01 YU YU40688A patent/YU46639B/sh unknown
- 1988-03-01 HU HU88976A patent/HU207860B/hu unknown
- 1988-03-01 NO NO880901A patent/NO170977C/no not_active IP Right Cessation
- 1988-03-01 NZ NZ223694A patent/NZ223694A/xx unknown
- 1988-03-01 PH PH36572A patent/PH24119A/en unknown
- 1988-03-01 EG EG115/88A patent/EG18398A/xx active
- 1988-03-01 AU AU12537/88A patent/AU583762B2/en not_active Expired
- 1988-03-01 FI FI880941A patent/FI91868C/sv not_active IP Right Cessation
- 1988-03-01 CN CN88101642A patent/CN1015057B/zh not_active Expired
- 1988-03-01 CZ CS881317A patent/CZ281257B6/cs not_active IP Right Cessation
- 1988-03-01 PL PL1988270925A patent/PL157897B1/pl unknown
- 1988-03-01 AR AR88310191A patent/AR244673A1/es active
- 1988-03-01 DD DD88313286A patent/DD272077A5/de unknown
- 1988-03-01 DK DK198801083A patent/DK173065B1/da not_active IP Right Cessation
- 1988-03-02 KR KR1019880002163A patent/KR900003492B1/ko not_active IP Right Cessation
- 1988-03-02 JP JP4945288A patent/JPH0710837B2/ja not_active Expired - Lifetime
-
1991
- 1991-12-30 GR GR91402162T patent/GR3003459T3/el unknown
-
1998
- 1998-03-30 BA BA980296A patent/BA98296A/bs unknown
-
2002
- 2002-05-28 NO NO2002004C patent/NO2002004I2/no unknown
- 2002-08-07 LU LU90944C patent/LU90944I2/fr unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI880941A0 (sv) | Förfarande för framställning av terapeutiskt användbara piperazinyl-heterocykliska föreningar | |
FI883064A (sv) | Förfarande för framställning av terapeutiskt användbara heterocykliska föreningar | |
FI882007A (sv) | Förfarande för framställning av inhibitorer för steroid-5- -reduktas | |
FI92934B (sv) | Analogiförfarande för framställning av terapeutiskt användbara 1-deoxinojirimycinderivat | |
FI90769C (sv) | Förfarande för framställning av terapeutiskt användbara triazolföreningar | |
FI880757A0 (sv) | Förfarande för framställning av terapeutiskt verkande omättade heterocykliska karboxamidderivat | |
FI881223A (sv) | Förfarande för framställning av terapeutiskt aktiva 9-aminotetrahydroakridiner och därmed närbesläktade föreningar | |
FI874459A0 (sv) | Förfarande för framställning av terapeutiskt användbara piperidinderivat | |
FI850654A0 (sv) | Förfarande för framställning av terapeutiskt användbara pleuromutilinderivator | |
FI94752C (sv) | Förfarande för framställning av terapeutiskt användbara propenonoximetrar | |
FI930723A (sv) | Förfarande för framställning av terapeutiskt aktiva tiazolidinderivat | |
FI880869A (sv) | Förfarande för framställning av terapeutiskt aktiva tetrazolderivat | |
FI93215C (sv) | Förfarande för framställning av terapeutiskt användbara aminoalkoxifenylderivat | |
FI884471A0 (sv) | Förfarande för framställning av terapeutiskt aktiva dihydropyridinföreningar | |
FI880467A (sv) | Förfarande för framställning av terapeutiskt användbara substituerade 3,4-dihydro-2H-benzopyraner | |
FI884910A0 (sv) | Förfarande för framställning av terapeutiskt användbart bensopyranderivat | |
FI104171B (sv) | Förfarande för framställning av mono-N-alkylerade polyazamakrocykliska föreningar | |
FI104075B1 (sv) | Förfarande för framställning av terapeutiskt användbara 2-karboxitienylkarbamoylpyrrolidin-4-ylkarbapenem-3-karboxylsyraderivat | |
FI893003A0 (sv) | Förfarande för framställning av terapeutiskt användbara neplanocinderivat | |
FI880716A (sv) | Förfarande för framställning av terapeutiskt användbara arylpiperazinylalkylenfenylsubstituerade heterocykliska föreningar | |
FI902316A0 (sv) | Förfarande för framställning av terapeutiskt verkande substituerade dihydropyrrolizinföreningar | |
FI98461B (sv) | Förfarande för framställning av terapeutiskt användbara föreningar | |
FI891144A0 (sv) | Förfarande för framställning av nya terapeutiskt användbara saltföreningar | |
FI903077A0 (sv) | Förfarande för framställning av terapeutiskt aktiva R(-)-3-kinuklidinolderivat | |
FI92188C (sv) | Förfarande för framställning av terapeutiskt användbara fenoxialkylpyrokatekolderivat |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
BB | Publication of examined application | ||
FG | Patent granted |
Owner name: PFIZER INC. |
|
MA | Patent expired |